![Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) - Penson - 2022 - Journal of Cachexia, Sarcopenia Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) - Penson - 2022 - Journal of Cachexia, Sarcopenia](https://onlinelibrary.wiley.com/cms/asset/83e131fa-4358-4154-937b-32dea662a544/jcsm12960-gra-0009-m.jpg)
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) - Penson - 2022 - Journal of Cachexia, Sarcopenia
![USRE42461E1 - Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents - Google Patents USRE42461E1 - Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents - Google Patents](https://patentimages.storage.googleapis.com/a2/58/31/8f67f47fe27598/USRE042461-20110614-C00010.png)
USRE42461E1 - Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents - Google Patents
![JDMF 220MF10122 of Teva Czech Industries S. R. O. | Japan Drug Master Files | JP DMF | Pharmacompass.com JDMF 220MF10122 of Teva Czech Industries S. R. O. | Japan Drug Master Files | JP DMF | Pharmacompass.com](https://www.pharmacompass.com/image/banner/teva-apigif-28899.gif)